Press Releases
Press Releases
P-MEC China and Co-Located Shows Provide Access to Growing Markets and Debut Zoning
Leading events organiser UBM Live today announced details of the forthcoming P-MEC China, to be hosted 26th to 28th June, 2012 at the SNIEC in Shanghai, China. P-MEC China, for pharmaceutical machinery and equipment resources, will be co-located...
Press Releases
New Zoning to Highlight High-Growth Sectors at China Pharma Events
Leading events organiser UBM Live today announced details of its annual schedule of China events for the global pharmaceutical market. Set to be hosted from 26th to 28th June at the SNIEC in Shanghai, CPhI China for pharmaceutical...
Press Releases
Advanced Cell Technology to Present at World Stem Cells & Regenerative Medicine Congress in London
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that chairman and CEO Gary Rabin will be presenting at the World Stem Cells and Regenerative Medicine Conference, May 21-23, in London. ...
Press Releases
HealthPartners launches Empower HSA Rx Plus
HealthPartners is working to ensure that members who have a high-deductible health plan (HDHP) and a health savings account (HSA) have more affordable access to preventive prescription drugs through the launch of the Empower HSA Rx Plus plan....
Press Releases
CoreLab Partners collaborates at industry conferences worldwide
CoreLab Partners, Inc, a leading independent core lab providing centralized cardiac safety services and medical imaging assessment, is set to attend and actively participate in several upcoming industry events around the world over the next several months. ...
Press Releases
IntegenX Names Biotechnology Veteran David V. Smith Chief Operating Officer
IntegenX Inc., a privately held company and leading developer of rapid human DNA identification technology, DNA sequencing library preparation systems, and DNA/RNA room temperature stability and storage products, today announced the appointment of David V. Smith as Chief...
Press Releases
Pfizer To Present New Data In Advanced Kidney, Lung And Hematologic Cancers At 2012 ASCO Annual Meeting
New data will be presented on targeted cancer treatments from the Pfizer Oncology portfolio across three key therapeutic categories, including tumors of the kidney, lung and hematologic malignancies, at the Annual Meeting of the American Society of Clinical...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read